05/08/2023
Uniting for the International Alopecia Day 2023!
Alopecia is a group of hair loss disorders caused among others by changes in the life cycle of hair follicles or inflammatory disorders - diseases that occur when the body's own tissues are attacked by its own immune system. To name a few, this group of diseases comprises Alopecia areata (AA), male and female pattern hair loss, scarring alopecias, telogen effluvium, and more. For example, AA - which usually results in non-scarring bald patches on the scalp or body up to complete hair loss (1) – has an estimated prevalence of approximately 1 in 1000 worldwide, with a lifetime risk of around 2%. The disease can develop rapidly at any age and affects both men and women (2, 3).
All forms of Alopecia have a significant negative impact on quality of life. Beyond the physical ailments, they cause psychological distress including high levels of anxiety and depression. Thus, finally, the scientific community has acknowledged Alopecia as a disease and not merely a cosmetic issue – this recognition will hopefully promote Alopecia awareness and research.
Also at QIMA Life Sciences, some team members or their families and friends are affected by Alopecia. This is why we are so passionate about supporting and promoting research on different forms of Alopecia. By focusing our efforts on Alopecia research, we hope to raise awareness and help improve existing treatments and develop new drugs.
If you are interested to learn more about hair biology and hair follicle diseases, as well as our research, feel free to request the replay of our free webinar presented by Bertolini 👉 https://qima-lifesciences.com/en/webinars-qimalifesciences/
Find all details about our Alopecia research on https://www.monasteriumlab.com/expertise/experimental-tests-and-outputs/hair-diseases/
Life Sciences
(1) Gilhar A, Etzioni A, Paus R., N Engl J Med, 2012. (2) Strazzulla LC et al., J Am Acad Dermatol., 2018. (3) Safavi KH et al., Mayo Clin Proc. 1995.
